Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane

Eugene A. Woltering, Rosemary Barrie, Thomas M. O'Dorisio, Dennis Arce, Tina Ure, Andrew Cramer, Douglas Holmes, Joseph Robertson, John Fassler

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

The mechanism responsible for alterations in tumor growth following administration of somatostatin analogues is unknown. Somatostatin analogues, SMS 201-995 and RC-160, have demonstrated the potential to inhibit both tumor growth and vascularity, in vivo and in vitro. We hypothesized that SMS and RC-160 inhibit angiogenesis and this inhibition may alter tumor growth. To test this hypothesis, 2 mm methylcellulose disks containing concentrations of SMS 201-995 and RC-160 at 0, 0.5, 2.5, or 50 μg per disk, were implanted on the chorioallantoic membrane (CAM) of 6- to 7-day-old shell-less chick embryos. Inhibition of blood vessel growth in the region of the disk was visually assessed 24-36 hr following disk implantation and graded (0-4) based on the radius of the zone of inhibition from the center of the disk. The overall incidence of inhibition for the somatostatin analogues at concentrations of 0.5, 2.5, and 50 μg per disk was 13, 56, and 61% for SMS and 27, 49, and 68% for RC-160, respectively. Overall incidence of inhibition for the positive (inhibitory) control was 70.5% and those for buffer (negative) controls were 3-14%. Somatostatin analogues were associated in a dose-related fashion with both a greater percentage of inhibition of blood vessel growth and an increased grade of inhibition. Inhibition of angiogenesis may be a mechanism responsible for the tumor regression observed in vivo following SMS or RC-160 therapy.

Original languageEnglish (US)
Pages (from-to)245-251
Number of pages7
JournalJournal of Surgical Research
Volume50
Issue number3
DOIs
StatePublished - 1991

Fingerprint

Chorioallantoic Membrane
Somatostatin
Growth
Octreotide
Blood Vessels
Neoplasms
Methylcellulose
Incidence
Chick Embryo
Buffers
vapreotide

ASJC Scopus subject areas

  • Surgery

Cite this

Woltering, E. A., Barrie, R., O'Dorisio, T. M., Arce, D., Ure, T., Cramer, A., ... Fassler, J. (1991). Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. Journal of Surgical Research, 50(3), 245-251. https://doi.org/10.1016/0022-4804(91)90186-P

Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. / Woltering, Eugene A.; Barrie, Rosemary; O'Dorisio, Thomas M.; Arce, Dennis; Ure, Tina; Cramer, Andrew; Holmes, Douglas; Robertson, Joseph; Fassler, John.

In: Journal of Surgical Research, Vol. 50, No. 3, 1991, p. 245-251.

Research output: Contribution to journalArticle

Woltering, EA, Barrie, R, O'Dorisio, TM, Arce, D, Ure, T, Cramer, A, Holmes, D, Robertson, J & Fassler, J 1991, 'Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane', Journal of Surgical Research, vol. 50, no. 3, pp. 245-251. https://doi.org/10.1016/0022-4804(91)90186-P
Woltering, Eugene A. ; Barrie, Rosemary ; O'Dorisio, Thomas M. ; Arce, Dennis ; Ure, Tina ; Cramer, Andrew ; Holmes, Douglas ; Robertson, Joseph ; Fassler, John. / Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. In: Journal of Surgical Research. 1991 ; Vol. 50, No. 3. pp. 245-251.
@article{48c0a84aa5eb4d3b83072dc79ade843d,
title = "Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane",
abstract = "The mechanism responsible for alterations in tumor growth following administration of somatostatin analogues is unknown. Somatostatin analogues, SMS 201-995 and RC-160, have demonstrated the potential to inhibit both tumor growth and vascularity, in vivo and in vitro. We hypothesized that SMS and RC-160 inhibit angiogenesis and this inhibition may alter tumor growth. To test this hypothesis, 2 mm methylcellulose disks containing concentrations of SMS 201-995 and RC-160 at 0, 0.5, 2.5, or 50 μg per disk, were implanted on the chorioallantoic membrane (CAM) of 6- to 7-day-old shell-less chick embryos. Inhibition of blood vessel growth in the region of the disk was visually assessed 24-36 hr following disk implantation and graded (0-4) based on the radius of the zone of inhibition from the center of the disk. The overall incidence of inhibition for the somatostatin analogues at concentrations of 0.5, 2.5, and 50 μg per disk was 13, 56, and 61{\%} for SMS and 27, 49, and 68{\%} for RC-160, respectively. Overall incidence of inhibition for the positive (inhibitory) control was 70.5{\%} and those for buffer (negative) controls were 3-14{\%}. Somatostatin analogues were associated in a dose-related fashion with both a greater percentage of inhibition of blood vessel growth and an increased grade of inhibition. Inhibition of angiogenesis may be a mechanism responsible for the tumor regression observed in vivo following SMS or RC-160 therapy.",
author = "Woltering, {Eugene A.} and Rosemary Barrie and O'Dorisio, {Thomas M.} and Dennis Arce and Tina Ure and Andrew Cramer and Douglas Holmes and Joseph Robertson and John Fassler",
year = "1991",
doi = "10.1016/0022-4804(91)90186-P",
language = "English (US)",
volume = "50",
pages = "245--251",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane

AU - Woltering, Eugene A.

AU - Barrie, Rosemary

AU - O'Dorisio, Thomas M.

AU - Arce, Dennis

AU - Ure, Tina

AU - Cramer, Andrew

AU - Holmes, Douglas

AU - Robertson, Joseph

AU - Fassler, John

PY - 1991

Y1 - 1991

N2 - The mechanism responsible for alterations in tumor growth following administration of somatostatin analogues is unknown. Somatostatin analogues, SMS 201-995 and RC-160, have demonstrated the potential to inhibit both tumor growth and vascularity, in vivo and in vitro. We hypothesized that SMS and RC-160 inhibit angiogenesis and this inhibition may alter tumor growth. To test this hypothesis, 2 mm methylcellulose disks containing concentrations of SMS 201-995 and RC-160 at 0, 0.5, 2.5, or 50 μg per disk, were implanted on the chorioallantoic membrane (CAM) of 6- to 7-day-old shell-less chick embryos. Inhibition of blood vessel growth in the region of the disk was visually assessed 24-36 hr following disk implantation and graded (0-4) based on the radius of the zone of inhibition from the center of the disk. The overall incidence of inhibition for the somatostatin analogues at concentrations of 0.5, 2.5, and 50 μg per disk was 13, 56, and 61% for SMS and 27, 49, and 68% for RC-160, respectively. Overall incidence of inhibition for the positive (inhibitory) control was 70.5% and those for buffer (negative) controls were 3-14%. Somatostatin analogues were associated in a dose-related fashion with both a greater percentage of inhibition of blood vessel growth and an increased grade of inhibition. Inhibition of angiogenesis may be a mechanism responsible for the tumor regression observed in vivo following SMS or RC-160 therapy.

AB - The mechanism responsible for alterations in tumor growth following administration of somatostatin analogues is unknown. Somatostatin analogues, SMS 201-995 and RC-160, have demonstrated the potential to inhibit both tumor growth and vascularity, in vivo and in vitro. We hypothesized that SMS and RC-160 inhibit angiogenesis and this inhibition may alter tumor growth. To test this hypothesis, 2 mm methylcellulose disks containing concentrations of SMS 201-995 and RC-160 at 0, 0.5, 2.5, or 50 μg per disk, were implanted on the chorioallantoic membrane (CAM) of 6- to 7-day-old shell-less chick embryos. Inhibition of blood vessel growth in the region of the disk was visually assessed 24-36 hr following disk implantation and graded (0-4) based on the radius of the zone of inhibition from the center of the disk. The overall incidence of inhibition for the somatostatin analogues at concentrations of 0.5, 2.5, and 50 μg per disk was 13, 56, and 61% for SMS and 27, 49, and 68% for RC-160, respectively. Overall incidence of inhibition for the positive (inhibitory) control was 70.5% and those for buffer (negative) controls were 3-14%. Somatostatin analogues were associated in a dose-related fashion with both a greater percentage of inhibition of blood vessel growth and an increased grade of inhibition. Inhibition of angiogenesis may be a mechanism responsible for the tumor regression observed in vivo following SMS or RC-160 therapy.

UR - http://www.scopus.com/inward/record.url?scp=0026069006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026069006&partnerID=8YFLogxK

U2 - 10.1016/0022-4804(91)90186-P

DO - 10.1016/0022-4804(91)90186-P

M3 - Article

C2 - 1705618

AN - SCOPUS:0026069006

VL - 50

SP - 245

EP - 251

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 3

ER -